Company page

Sinovac Biotech, Ltd.

Sinovac Biotech, Ltd. is a public company traded under the ticker SVA in the American market. The company has a market capitalization of approximately $464.9 million. Sinovac focuses on the development and commercialization of vaccines and biopharmaceutical products.

SVA:NASDAQUpdated July 31, 2026
Sinovac Biotech, Ltd. logo
Ticker
SVA:NASDAQ
Asset type
Stock
Market cap
$464.9M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD